At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 03 Feb 2000 Profile reviewed but no new development reported
- 03 Feb 2000 No-Development-Reported for Cancer in USA (Unknown route)
- 29 May 1997 New profile